Barbara Ryan

@barbara_ryan12

Pharma analyst, biopharma consultant, CNBC Contributor, passion for biopharma, financial markets, tennis, her children, friends, cooking,music,fashion,dancing.

Vrijeme pridruživanja: listopad 2012.

Tweetovi

Blokirali ste korisnika/cu @barbara_ryan12

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @barbara_ryan12

  1. proslijedio/la je Tweet
    4. velj

    Dad on bloomberg... the bond market and the coronavirus

    Prikaži ovu nit
    Poništi
  2. 4. velj
    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Here is my article on health as the new stock option 👇🏻👊🏻 Your Health is Your Wealth: How to Assess Your Employer’s Approach to Health > CEOWORLD magazine

    Poništi
  4. proslijedio/la je Tweet
    3. velj

    If you're in healthcare and in the Boston area on 2.18 + want to improve your game, this is a great opportunity to hear from one of healthcare's most respected leaders. is a board member, a professor at Columbia, and now an author.She brings great real world experience.

    Poništi
  5. proslijedio/la je Tweet
    3. velj

    link: Ascending Davos: A Career Journey from the Emergency Room to the Boardroom - Massachusetts Biotechnology Council

    Poništi
  6. 2. velj

    'We can do better': BIO's first breakdown of diversity in member companies

    Poništi
  7. proslijedio/la je Tweet
    2. velj

    RSVP Book launch Boston! Thanks for hosting my healthcare story. All book proceeds go 🤘🏻👇🏻Ascending Davos: A Career Journey from the Emergency Room to the Boardroom - Massachusetts Biotechnology Council

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    28. stu 2019.

    So we were an early adopter on the “airbnb-JPM”. Fat pad, roof deck and up a hill. People checked in and never checked out. I cant go into the evening details as NDAs were signed. The 10 min walk is a BFD for the speed daters.

    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    23. sij
    Poništi
  10. proslijedio/la je Tweet
    22. sij

    After decades of determined research, RNAi drugs have their day in the sun - MedCity News ⁦⁩ ⁦⁩ ⁦⁩ ⁦

    Poništi
  11. proslijedio/la je Tweet
    22. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    Thanks for participating in our conference! Great panel.

    Poništi
  12. proslijedio/la je Tweet
    21. sij

    Our CEO, Dietrich Stephan, was part of ’s panel, moderated by 's Edward Tenthoff discussing antisense therapeutics like . It also featured , , and

    Poništi
  13. 20. sij

    Check out my latest article: Fabulous Pharma Females Unite via

    Poništi
  14. proslijedio/la je Tweet
    16. sij

    Its my last day so let me just be raw and real. If you run a fund, firm, factory and don’t have women as part of top management/board YOU are bad at math. We aren’t a diversity hire rather the money and power source running healthcare decisions througout the system.

    Poništi
  15. proslijedio/la je Tweet
    13. sij

    JPM hotels are now $1000/night+ and this year the complimentary coffee is $8 and the lobby seats are called “pods” which cost $1000 for the chairs/4hr/slots plus $1000 minimum for food. Got Orlando????

    Poništi
  16. proslijedio/la je Tweet
    9. sij

    It has been such a joy and privilege to work with and ! So excited to see what the future holds! Congratulations!

    Poništi
  17. proslijedio/la je Tweet
    10. sij
    Poništi
  18. proslijedio/la je Tweet
    9. sij
    Poništi
  19. proslijedio/la je Tweet
    8. sij

    Commences Phase 1 trial with AGEN1223 - a novel bispecific designed to deplete Tregs from the tumor microenvironment. First patient dosed DEC19, study ongoing with combinations planned.

    Poništi
  20. proslijedio/la je Tweet
    20. pro 2019.

    We are excited to announce in collaboration with , Dr. Steven O'Day, Executive Director of JWCI, is working on a combination study with two novel CTLA-4 and PD-1 immunotherapy drugs for patients with advanced cancers. Read the press release:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·